Enhanced Theranostic Efficacy of <superscript>89</superscript>Zr and <superscript>177</superscript>Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice.
In: Molecular Pharmaceutics, Jg. 21 (2024-05-06), Heft 5, S. 2544-2554
academicJournal
Zugriff:
Titel: |
Enhanced Theranostic Efficacy of <superscript>89</superscript>Zr and <superscript>177</superscript>Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice.
|
---|---|
Autor/in / Beteiligte Person: | Chen, Zhao ; Yang, Qi ; Song, Lele ; Qiu, Yongkang ; Wang, Tianyao ; Wu, Sitong ; Huang, Wenpeng ; Sun, Xinyao ; Wang, Aixiang ; Kang, Lei |
Zeitschrift: | Molecular Pharmaceutics, Jg. 21 (2024-05-06), Heft 5, S. 2544-2554 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 1543-8384 (print) |
DOI: | 10.1021/acs.molpharmaceut.4c00084 |
Sonstiges: |
|